Recursion Pharmaceuticals, Inc. - RXRX

SEC FilingsOur RXRX Tweets

About Gravity Analytica

Recent News

  • 06.10.2025 - Goldman Sachs 46th Annual Global Healthcare Conference
  • 06.10.2025 - Goldman Sachs 46th Annual Global Healthcare Conference
  • 06.06.2025 - MIT and Recursion Release Boltz-2: Next Generation AI Model to Predict Binding Affinity at Unprecedented Speed, Scale, and Accuracy
  • 06.06.2025 - MIT and Recursion Release Boltz-2: Next Generation AI Model to Predict Binding Affinity at Unprecedented Speed, Scale, and Accuracy
  • 06.05.2025 - Jefferies Global Healthcare Conference
  • 06.05.2025 - Jefferies Global Healthcare Conference
  • 05.30.2025 - Recursion to Participate in Upcoming Investor Conferences
  • 05.30.2025 - Recursion to Participate in Upcoming Investor Conferences
  • 05.15.2025 - J.P. Morgan 53rd Annual Global Technology, Media and Communications Conference
  • 05.15.2025 - J.P. Morgan 53rd Annual Global Technology, Media and Communications Conference

Recent Filings

  • 05.19.2025 - 4 Statement of changes in beneficial ownership of securities
  • 05.19.2025 - 4 Statement of changes in beneficial ownership of securities
  • 05.19.2025 - 4 Statement of changes in beneficial ownership of securities
  • 05.09.2025 - 8-K Current report
  • 05.09.2025 - 424B7 Prospectus [Rule 424(b)(7)]